COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Carvolix is born and funded
French medtech company Affluent Medical rebrands as Carvolix after acquiring Caranx Medical and Artedrone. Completes 10m€ financing with Truffle Capital and Edwards Lifesciences for breakthrough AI-driven mini-robots and biomimetic implants in interventional cardiology and brain stroke treatment. Focus on expanding market and long-term value creation -
-
-
-
COMMUNIQUÉ DE PRESSE
Verve Group SE Announces Intention to Issue Subsequent Bonds to Capitalize on Business Momentum Following Strong Q4 Performance
Verve Group SE intends to issue subsequent bonds following strong Q4 performance to capitalize on business momentum. The Company plans an aggregate total of €50 million -
COMMUNIQUÉ DE PRESSE
Affluent Medical officially becomes CARVOLIX
Affluent Medical officially becomes CARVOLIX after completing the acquisitions of CARANX MEDICAL and ARTEDRONE, with a 10m€ first tranche of financing. Carvolix focuses on revolutionizing cardiac valve replacement and brain stroke treatment -
COMMUNIQUÉ DE PRESSE
Julius Baer Group announces changes to the Board of Directors
Julius Baer Group announces changes to the Board of Directors, including Richard Campbell-Breeden stepping down as Vice Chairman and Juerg Hunziker succeeding him. Urban Angehrn to join the Board as independent non-executive Director -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Update of a release from 24/08/2025, 19:30 CET/CEST - Intended changes in the group structure at the level of the majority shareholder Highlight Event and Entertainment AG
Update on changes in group structure of Highlight Event and Entertainment AG, including planned capital increase with new investor CSL Mindset Ltd -
